breseq version 0.35.4 revision f352f80f4bc9
mutation predictions | marginal predictions | summary statistics | genome diff | command line log |
Marginal read alignment evidence (highest frequency 20 of 47 shown, sorted by frequency from high to low) | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
seq id | position | ref | new | freq | score (cons/poly) | reads | annotation | genes | product | ||
* | NZ_CP009273 | 518,782 | 0 | T | G | 64.7% | 2.0 / 11.1 | 17 | G22G (GGT→GGG) | rhsD | rhs element protein RhsD |
* | NZ_CP009273 | 4,058,958 | 0 | G | A | 64.7% | ‑4.6 / 14.7 | 17 | L57L (CTG→TTG) | yihO | MFS transporter |
* | NZ_CP009273 | 799,325 | 0 | G | T | 60.0% | 2.8 / 17.5 | 15 | V123L (GTG→TTG) | ybhJ | hydratase |
* | NZ_CP009273 | 1,213,865 | 0 | G | T | 60.0% | 2.2 / 18.0 | 15 | S361I (AGT→ATT) | pdeG | cyclic diguanylate phosphodiesterase |
* | NZ_CP009273 | 3,126,661 | 0 | T | G | 60.0% | 1.4 / 16.0 | 15 | H219P (CAC→CCC) | yghS | dTMP kinase |
* | NZ_CP009273 | 3,175,957 | 0 | A | T | 59.1% | 8.3 / 25.1 | 23 | I17F (ATT→TTT) | zupT | zinc transporter ZupT |
* | NZ_CP009273 | 2,356,900 | 0 | T | C | 58.3% | 0.3 / 11.6 | 13 | G71G (GGA→GGG) | yfaY | nicotinamide mononucleotide deamidase‑related protein YfaY |
* | NZ_CP009273 | 982,470 | 0 | A | C | 54.5% | 4.5 / 10.8 | 11 | intergenic (‑32/+571) | ompF/asnS | porin OmpF/asparagine‑‑tRNA ligase |
* | NZ_CP009273 | 4,594,167 | 0 | C | T | 54.3% | 16.0 / 46.3 | 35 | S64F (TCT→TTT) | bglJ | DNA‑binding transcriptional activator BglJ |
* | NZ_CP009273 | 2,141,214 | 0 | T | G | 53.8% | 25.2 / 37.1 | 26 | G20G (GGT→GGG) | yegD | molecular chaperone |
* | NZ_CP009273 | 832,048 | 0 | T | G | 52.5% | 43.5 / 56.4 | 40 | V81G (GTC→GGC) | hcxB | hydroxycarboxylate dehydrogenase HcXB |
* | NZ_CP009273 | 1,329,948 | 0 | T | G | 51.7% | 30.8 / 38.3 | 29 | intergenic (+24/‑140) | BW25113_RS25560/acnA | hypothetical protein/aconitate hydratase AcnA |
* | NZ_CP009273 | 4,612,067 | 0 | A | G | 51.6% | 28.4 / 46.1 | 31 | E161G (GAG→GGG) | yjjJ | type II toxin‑antitoxin system HipA family toxin YjjJ |
* | NZ_CP009273 | 4,594,161 | 0 | C | T | 51.4% | 18.5 / 49.1 | 35 | S62F (TCT→TTT) | bglJ | DNA‑binding transcriptional activator BglJ |
* | NZ_CP009273 | 2,371,314 | 0 | G | A | 50.0% | 19.3 / 10.4 | 26 | F475F (TTC→TTT) | menD | 2‑succinyl‑5‑enolpyruvyl‑6‑hydroxy‑3‑ cyclohexene‑1‑carboxylic‑acid synthase |
* | NZ_CP009273 | 4,224,171 | 0 | A | C | 48.1% | 22.8 / 11.6 | 27 | P162P (CCA→CCC) | pgi | glucose‑6‑phosphate isomerase |
* | NZ_CP009273 | 2,141,241 | 0 | C | A | 48.0% | 31.0 / 13.0 | 25 | N29K (AAC→AAA) | yegD | molecular chaperone |
* | NZ_CP009273 | 832,042 | 0 | C | G | 47.1% | 29.3 / 13.8 | 34 | A79G (GCG→GGG) | hcxB | hydroxycarboxylate dehydrogenase HcXB |
* | NZ_CP009273 | 937,169 | 0 | T | G | 44.8% | 22.8 / 17.4 | 29 | V252G (GTG→GGG) | dmsA | dimethylsulfoxide reductase subunit A |
* | NZ_CP009273 | 4,245,989 | 0 | C | T | 44.7% | 36.4 / 22.5 | 47 | E136K (GAA→AAA) | plsB | glycerol‑3‑phosphate 1‑O‑acyltransferase PlsB |